This trial is a phase 3 study to evaluate efficacy and safety of co-administrated temisartan/amlodipine and rosuvastatin in subjects with hypertension and hyperlipidemia.~In Temisartan/Amlodipine/Rosuvastatin treatment group, 60 subjects will be assigned and the subjects administer Temisartan/Amlodipine/Rosuvastatin 8 for weeks.~In Temisartan/Amlodipine treatment group, 60 subjects will be assigned and the subjects administer Temisartan/Amlodipine for 8 weeks.~In Temisartan/Rosuvastatin treatment group, 60 subjects will be assigned and the subjects administer Temisartan/Rosuvastatin for 8 weeks.
Randomized, double-blind, active-controlled, multicenter phase 3 trial to evaluate efficacy and safety of co-administrated temisartan/amlodipine and rosuvastatin in subjects with hypertension and hyperlipidemia.